Adagio Medical Holdings, Inc.
ADGM
$0.99
-$0.02-1.98%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | -74.77% | -19.30% | 116.54% | 100.67% | 144.59% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -74.77% | -19.30% | 116.54% | 100.67% | 144.59% |
| Cost of Revenue | 0.94% | 48.48% | 97.97% | 154.06% | 68.57% |
| Gross Profit | -26.86% | -67.63% | -94.07% | -169.98% | -52.35% |
| SG&A Expenses | -33.31% | 11.07% | 26.47% | 73.55% | 98.78% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -16.12% | 5.39% | 12.34% | 25.91% | 10.13% |
| Operating Income | 15.11% | -5.72% | -11.42% | -25.11% | -9.10% |
| Income Before Tax | -193.12% | -122.30% | -109.87% | -103.60% | 22.00% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -193.12% | -122.30% | -109.87% | -103.60% | 22.00% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -193.12% | -122.30% | -109.87% | -103.60% | 22.00% |
| EBIT | 15.11% | -5.72% | -11.42% | -25.11% | -9.10% |
| EBITDA | 15.86% | -4.22% | -9.70% | -22.48% | -7.28% |
| EPS Basic | 82.47% | 88.46% | 74.32% | 55.38% | 35.47% |
| Normalized Basic EPS | 93.38% | 95.91% | 81.15% | 61.94% | 35.47% |
| EPS Diluted | 82.10% | 88.21% | 74.29% | 55.38% | 35.47% |
| Normalized Diluted EPS | 93.37% | 96.04% | 81.27% | 62.05% | 35.59% |
| Average Basic Shares Outstanding | 407.22% | 1,713.25% | 1,247.80% | 777.59% | 299.28% |
| Average Diluted Shares Outstanding | 356.44% | 1,757.00% | 1,291.82% | 821.94% | 343.70% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |